Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Positively Charged Anticancer Nanoparticles Accumulate in the Acidic Microenvironment of a Tumor

By BiotechDaily International staff writers
Posted on 24 Jul 2013
Print article
Nanoparticles containing an anticancer drug within a weak polybase sphere accumulate inside tumors where the acidic environment promotes their retention and induces swelling, which enhances delivery of the chemotherapeutic load.

Investigators at Purdue University (West Lafayette, IN, USA) coined the term "pH phoresis" to describe the tendency of nanoparticles composed of weak polybases (such as polyamines) to migrate to areas of negative charge when exposed to a pH gradient.

Furthermore, in regions of lower pH—such as in the pH 6.5-6.9 microenvironment surrounding a tumor—increased protonation of the amines in the shell cause them to repel each other, which forces the particles to expand in size. Doubling the size of the particles would, in theory, result in a similar increase in the efficiency of drug delivery to tumors.

"This phenomenon, which we term pH phoresis, may provide a useful mechanism for improving the delivery of drugs to cancer cells in solid tumor tissues," said first author Dr. You-Yeon Won, associate professor of chemical engineering at Purdue University. "Such an effect would be a game changer by delivering the proper dose of anticancer drugs inside tumor cells. This pH phoresis concept also could be combined readily within other established drug-delivery methodologies, making it potentially practical for medical application."

Related Links:
Purdue University




Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.